In the present study we investigated the prognostic and cetuximab-response prediction significance of aberrant methylation and the expression status of B4GALT1 in 1418 CRC patients from multiple cohorts of the Gene Expression Omnibus (GEO) public data repository and The Cancer Genome Atlas (TCGA) database. This evidence concerns the gene B4GALT1 and colorectal carcinoma.